NASDAQ · UNH
Healthcare · Medical - Healthcare Plans
$376.32
Down-$0.34 (-0.09%)
Updated Oct 7, 2026, 9:46 PM
SID Score
7.1/10
Composite research score
Smart Money
40/100
Neutral
Price performance · UNH
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
UNH closed at $376.32 after 21 trading sessions, down 6.12% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $379.03 | $380.41 | $373.70 | $376.32 | 5.04M |
| Oct 5, 2026 | $372.33 | $379.14 | $368.0501 | $378.58 | 5.83M |
| Oct 2, 2026 | $365.14 | $372.68 | $364.47 | $371.90 | 3.31M |
| Oct 1, 2026 | $367.99 | $371.86 | $362.60 | $365.20 | 3.94M |
| Sep 30, 2026 | $374.93 | $374.93 | $365.72 | $367.08 | 4.79M |
| Sep 29, 2026 | $374.88 | $376.59 | $371.33 | $374.94 | 3.29M |
| Sep 28, 2026 | $376.36 | $380.98 | $374.56 | $377.83 | 4.68M |
| Sep 25, 2026 | $375.95 | $379.17 | $371.17 | $376.59 | 4.08M |
| Sep 24, 2026 | $371.92 | $375.28 | $368.501 | $375.01 | 4.65M |
| Sep 23, 2026 | $370.89 | $372.61 | $366.00 | $371.29 | 3.86M |
| Sep 22, 2026 | $381.39 | $381.39 | $372.41 | $372.95 | 4.5M |
| Sep 21, 2026 | $377.87 | $378.95 | $373.82 | $377.56 | 5.71M |
| Sep 18, 2026 | $375.29 | $378.49 | $372.42 | $376.90 | 8.62M |
| Sep 17, 2026 | $376.45 | $380.50 | $374.20 | $375.21 | 4.84M |
| Sep 16, 2026 | $375.90 | $380.22 | $373.63 | $375.26 | 4.42M |
| Sep 15, 2026 | $383.55 | $383.80 | $375.50 | $375.93 | 4.39M |
| Sep 14, 2026 | $381.44 | $386.46 | $379.2814 | $383.55 | 4.48M |
| Sep 11, 2026 | $390.42 | $391.73 | $375.90 | $379.09 | 7.48M |
| Sep 10, 2026 | $396.00 | $399.265 | $387.60 | $388.28 | 4.35M |
| Sep 9, 2026 | $405.17 | $406.53 | $378.0801 | $393.06 | 7.74M |
| Sep 8, 2026 | $392.40 | $403.885 | $390.44 | $400.84 | 7.05M |
The latest Smart Investors Daily articles mentioning UNH.
Company
Market Activity
Research & News
UNH research
Company profile and research snapshot.
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 21, 2026 | Mizuho | Outperform | — |
| Jul 21, 2026 | JP Morgan | Overweight | — |
| Jul 20, 2026 | Barclays | Overweight | — |
| Jul 17, 2026 | RBC Capital | Outperform | — |
| Jul 17, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 7, 2026
On October 4, Suze Orman, the personal finance author and former CNBC host, had a warning for her podcast listeners covered by UnitedHealth Group (NYSE:UNH): “If you have UnitedHealth Group, about 390,000 people are part of plans that are shutting down.” She said Humana (NYSE:HUM) will cut plans covering about 600,000 people. She also said […]
Yahoo · Oct 7, 2026
CNC's improving Medicaid margins, stronger Marketplace profitability and earnings recovery support its valuation, but sustainability remains the key test.
Yahoo · Oct 7, 2026
Key TakeawaysUnitedHealth raised its dividend to $9. 28 a share a year in the second quarter of 2026, while CVS still pays $2.
SeekingAlpha · Oct 7, 2026
Raul Shah details the 2nd most powerful tax strategy behind Roth conversions, tax gain harvesting.
Interpretive context generated from the platform’s current data sources.
UnitedHealth Group shares closed at $376.32, reflecting a daily decline of approximately 1.02%, per SID market data. The stock has experienced notable short-term pressure, declining 5.58% over the past month and 11.59% over the trailing three months. Despite this recent weakness, UNH has delivered a 16.43% gain over the past twelve months, demonstrating longer-term resilience. The stock currently trades below its 50-day moving average of $392.90, indicating near-term bearish momentum, but remains well above its 200-day moving average of $349.54, which suggests the broader uptrend remains intact. The 14-day RSI sits at 53.2, placing UNH in neutral territory between overbought and oversold conditions, according to Massive/Polygon technical data. Average daily volume stands at approximately 8.77 million shares. The stock carries a beta of 0.432, reflecting significantly lower volatility than the broader market, consistent with its defensive healthcare sector positioning.
UnitedHealth Group currently carries a market capitalization of approximately $305 billion, maintaining its position as the largest company in the healthcare sector by market value, per SID market data. The stock trades at a price-to-earnings ratio of 17.38, which sits below the S&P 500 average and reflects a moderate valuation relative to the company's scale and earnings power. The price-to-book ratio stands at 3.19, according to SEC filings, indicating the market values UNH at more than three times its book value. The PEG ratio is negative at -1.02, suggesting complexities in forward growth estimates that warrant further examination. UnitedHealth offers a dividend yield of 2.59%, providing a meaningful income component for shareholders. Within the healthcare sector, UNH's valuation metrics reflect a balance between its dominant market position in managed care and insurance services and the regulatory headwinds facing the broader industry.
UnitedHealth Group's smart money composite score stands at 40 out of 100, reflecting a neutral overall signal, per SID market data. Institutional positioning is notably strong, scoring a perfect 25 out of 25, indicating robust confidence from large asset managers and funds based on 13F institutional filings. In contrast, insider activity scores 0 out of 25, despite 20 insider transactions recorded over the past 90 days — all of which were purchases with zero sells, according to SEC Form 4 filings. This unanimous buying pattern among insiders suggests management confidence, though the low composite insider score may reflect the relatively small dollar amounts involved. Dark pool activity registers at 8.6 out of 25, indicating below-average institutional block trading volume in off-exchange venues. Congressional trading activity scores 6.4 out of 25, showing limited but present legislative interest. The divergence between perfect institutional scores and low insider composite scores creates a mixed signal profile that requires monitoring across multiple data streams for directional clarity.
UnitedHealth Group has delivered consecutive earnings beats in its two most recent reported quarters, according to company earnings reports. In the most recent quarter reported on April 21, 2026, UNH posted earnings per share of $7.23 against a consensus estimate of $6.56, representing a positive surprise of $0.67 or approximately 10.2%. The prior quarter reported on July 16, 2026 showed an even larger beat, with actual EPS of $6.38 versus estimates of $4.85, a surprise of $1.53 or roughly 31.5%. Looking ahead, analyst estimates project EPS of $4.14 for each of the next two upcoming quarters, scheduled for October 13 and October 27, 2026. The sequential decline in estimated EPS from the $7.23 and $6.38 reported in recent quarters to $4.14 reflects typical seasonality patterns in UnitedHealth's managed care and pharmacy benefit operations rather than fundamental deterioration.
Wall Street analysts maintain a uniformly bullish stance on UnitedHealth Group, with all five most recent ratings reaffirming positive outlooks, per Wall Street analyst reports. On July 21, 2026, Mizuho reiterated its Outperform rating while JP Morgan maintained its Overweight designation, signaling continued conviction from two major sell-side firms. Barclays similarly reaffirmed its Overweight rating on July 20, 2026. Earlier that week, both RBC Capital and UBS maintained their Outperform and Buy ratings, respectively, on July 17, 2026. Notably, none of the recent analyst actions involved downgrades or target price reductions, according to SID consensus data. The unanimous positive sentiment across these five firms is significant given the stock's 11.59% decline over three months, suggesting analysts view the recent pullback as a potential entry point rather than a fundamental concern. The consistency of maintained ratings rather than initiations indicates these firms have established long-term constructive views on UNH's business trajectory.
The latest Smart Investors Daily articles mentioning UNH.
